Does GLASDEGIB Cause Disease progression? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Disease progression have been filed in association with GLASDEGIB (Daurismo). This represents 1.3% of all adverse event reports for GLASDEGIB.
7
Reports of Disease progression with GLASDEGIB
1.3%
of all GLASDEGIB reports
6
Deaths
1
Hospitalizations
How Dangerous Is Disease progression From GLASDEGIB?
Of the 7 reports, 6 (85.7%) resulted in death, 1 (14.3%) required hospitalization.
Is Disease progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GLASDEGIB. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does GLASDEGIB Cause?
Death (102)
Febrile neutropenia (86)
Pneumonia (50)
Off label use (29)
Neoplasm progression (28)
Neutropenia (26)
Electrocardiogram qt prolonged (18)
Sepsis (18)
Pyrexia (17)
Septic shock (16)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which GLASDEGIB Alternatives Have Lower Disease progression Risk?
GLASDEGIB vs GLATIRAMER
GLASDEGIB vs GLECAPREVIR\PIBRENTASVIR
GLASDEGIB vs GLEEVEC
GLASDEGIB vs GLICLAZIDE
GLASDEGIB vs GLIMEPIRIDE